Perpinia, A.S.; Kadoglou, N.; Vardaka, M.; Gkortzolidis, G.; Karavidas, A.; Marinakis, T.; Papachrysostomou, C.; Makaronis, P.; Vlachou, C.; Mantzourani, M.;
et al. Pharmaceutical Prevention and Management of Cardiotoxicity in Hematological Malignancies. Pharmaceuticals 2022, 15, 1007.
https://doi.org/10.3390/ph15081007
AMA Style
Perpinia AS, Kadoglou N, Vardaka M, Gkortzolidis G, Karavidas A, Marinakis T, Papachrysostomou C, Makaronis P, Vlachou C, Mantzourani M,
et al. Pharmaceutical Prevention and Management of Cardiotoxicity in Hematological Malignancies. Pharmaceuticals. 2022; 15(8):1007.
https://doi.org/10.3390/ph15081007
Chicago/Turabian Style
Perpinia, Anastasia Stella, Nikolaos Kadoglou, Maria Vardaka, Georgios Gkortzolidis, Apostolos Karavidas, Theodoros Marinakis, Chrysostomi Papachrysostomou, Panagiotis Makaronis, Charikleia Vlachou, Marina Mantzourani,
and et al. 2022. "Pharmaceutical Prevention and Management of Cardiotoxicity in Hematological Malignancies" Pharmaceuticals 15, no. 8: 1007.
https://doi.org/10.3390/ph15081007
APA Style
Perpinia, A. S., Kadoglou, N., Vardaka, M., Gkortzolidis, G., Karavidas, A., Marinakis, T., Papachrysostomou, C., Makaronis, P., Vlachou, C., Mantzourani, M., Farmakis, D., & Konstantopoulos, K.
(2022). Pharmaceutical Prevention and Management of Cardiotoxicity in Hematological Malignancies. Pharmaceuticals, 15(8), 1007.
https://doi.org/10.3390/ph15081007
